|
Name |
Mellein
|
Molecular Formula | C10H10O3 | |
IUPAC Name* |
8-hydroxy-3-methyl-3,4-dihydroisochromen-1-one
|
|
SMILES |
CC1CC2=C(C(=CC=C2)O)C(=O)O1
|
|
InChI |
InChI=1S/C10H10O3/c1-6-5-7-3-2-4-8(11)9(7)10(12)13-6/h2-4,6,11H,5H2,1H3
|
|
InChIKey |
KWILGNNWGSNMPA-UHFFFAOYSA-N
|
|
Synonyms |
Mellein; Ochracin; 17397-85-2; 3,4-Dihydro-8-hydroxy-3-methylisocoumarin; 8-hydroxy-3-methylisochroman-1-one; AO-2; (+/-)-MELLEIN; 8-hydroxy-3-methyl-3,4-dihydroisochromen-1-one; 1200-93-7; 3,4-dihydro-8-hydroxy-3-methyl-1H-2-benzopyran-1-one; 8-hydroxy-3-methyl-3,4-dihydro-1H-2-benzopyran-1-one; 8-HYDROXY-3-METHYL-ISOCHROMAN-1-ONE; 1H-2-Benzopyran-1-one, 3,4-dihydro-8-hydroxy-3-methyl-; ISOCOUMARIN, 3,4-DIHYDRO-8-HYDROXY-3-METHYL-; CHEMBL226090; CHEBI:38760; 8-Hydroxy-3-methyl-3,4-dihydro-1H-isochromen-1-one; 3,4-Dihydro-8-hydroxy-3-methyl-(1H)-2-benzopyran-1-one; (R)-(-)-Mellein; Antibiotic AO-2; Antibiotic BV-1; (R)-3,4-Dihydro-8-hydroxy-3-methyl-1H-2-benzopyran-1-one; (R)-Mellein; BV-1; starbld0003745; (.+/-.)-Mellein; ALM-9; SCHEMBL1230955; SCHEMBL13925643; DTXSID60891794; BDBM50208249; AKOS006228659; 3-methyl-8-hydroxy-3,4-dihydroisocoumarin; CS-0225132; E82508; EN300-1228708; Q6813065; 3-Methyl-8-hydroxy-3,4-dihydro-1H-2-benzopyran-1-one; Z1198723372; Isocoumarin, 3,4-dihydro-8-hydroxy-3-methyl, (.+/-.)-; 3,4-Dihydro-8-hydroxy-3-methyl-1H-2-benzopyran-1-one, (.+/-.)-
|
|
CAS | 1200-93-7 | |
PubChem CID | 28516 | |
ChEMBL ID | CHEMBL226090 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 178.18 | ALogp: | 2.4 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 13 | QED Weighted: | 0.618 |
Caco-2 Permeability: | -4.539 | MDCK Permeability: | 0.00002860 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.338 |
Blood-Brain-Barrier Penetration (BBB): | 0.511 | Plasma Protein Binding (PPB): | 90.88% |
Volume Distribution (VD): | 0.904 | Fu: | 6.77% |
CYP1A2-inhibitor: | 0.911 | CYP1A2-substrate: | 0.343 |
CYP2C19-inhibitor: | 0.326 | CYP2C19-substrate: | 0.232 |
CYP2C9-inhibitor: | 0.157 | CYP2C9-substrate: | 0.882 |
CYP2D6-inhibitor: | 0.681 | CYP2D6-substrate: | 0.667 |
CYP3A4-inhibitor: | 0.225 | CYP3A4-substrate: | 0.18 |
Clearance (CL): | 14.132 | Half-life (T1/2): | 0.72 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.108 |
Drug-inuced Liver Injury (DILI): | 0.7 | AMES Toxicity: | 0.137 |
Rat Oral Acute Toxicity: | 0.066 | Maximum Recommended Daily Dose: | 0.103 |
Skin Sensitization: | 0.57 | Carcinogencity: | 0.891 |
Eye Corrosion: | 0.165 | Eye Irritation: | 0.974 |
Respiratory Toxicity: | 0.257 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000856 | 1.000 | D0H6QU | 0.310 | ||||
ENC005578 | 0.667 | D07MGA | 0.276 | ||||
ENC003945 | 0.638 | D09OQV | 0.266 | ||||
ENC004829 | 0.638 | D04JHN | 0.263 | ||||
ENC005856 | 0.636 | D07HBX | 0.260 | ||||
ENC005091 | 0.633 | D02NSF | 0.256 | ||||
ENC005939 | 0.574 | D06BYV | 0.250 | ||||
ENC005249 | 0.574 | D0L1WV | 0.250 | ||||
ENC002309 | 0.574 | D0WE3O | 0.247 | ||||
ENC002572 | 0.564 | D0E9CD | 0.245 |